Sfoglia per Rivista
Assortimento per gli aplotipi del sistema HLA come possibile meccanismo di selezione genetica o zigotica
1969-01-01 A. PIAZZA; MATTIUZ P.L.; CEPPELLINI R.
AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN MULTIPLE MYELOMA: THE GITMO EXPERIENCE
2003-01-01 Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavaro P; Rotta M; Aitoro G; Corradini P; Todisco E; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Messina M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
2016-01-01 Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.*
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS
2015-01-01 Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
2015-01-01 Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Pasquale, R; Sica, S; Laurenti, L
Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin.
1988-01-01 VISANI G ;RIZZOLI V ;DINOTA A ;AGLIETTA M ;BERNABEI PA ;GERACI L ;LEONI P ;MANGONI L ;MELONI G ;MOTTA MR
Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis
2002-01-01 Fabris, Fabrizio; Fagioli, Franca; Basso, Giuseppe; Girolami, Antonio
B lymphocytes receptors: a new biological approach for immunofluorescence studies.
1977-01-01 CONTE PF ;BOCCADORO M ;PILERI A
A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines
2019-01-01 D'Agaro T.; Zucchetto A.; Vit F.; Bittolo T.; Tissino E.; Rossi F.M.; Degan M.; Zaja F.; Bulian P.; Bo M.D.; Ferrero S.; Ladetto M.; Zamo A.; Gattei V.; Bomben R.
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial
2018-01-01 Bomben, Riccardo; Ferrero, Simone; D'Agaro, Tiziana; Dal Bo, Michele; Re, Alessandro; Evangelista, Andrea; Carella, Angelo Michele; Zamò, Alberto; Vitolo, Umberto; Omedè, Paola; Rusconi, Chiara; Arcaini, Luca; Rigacci, Luigi; Luminari, Stefano; Piccin, Andrea; Liu, Delong; Wiestner, Adrien; Gaidano, Gianluca; Cortelazzo, Sergio; Ladetto, Marco; Gattei, Valter
Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress
2011-01-01 L. Oliva; G. Palladini; F. Cerruti; N. Pengo; P. Cascio; R. Sitia; G. Merlini; S. Cenci
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation.
2014-01-01 Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
2019-01-01 Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
2006-01-01 Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy.
2014-01-01 Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A
Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse
2005-01-01 MATTEI D; MORDINI N; VIGNA TAGLIANTI R; BRUNO B; RAPEZZI D; GALLAMINI A
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation
2006-01-01 BRUNO B; PATRIARCA F; SORASIO R; MATTEI D; MONTEFUSCO V; PECCATORI J; BONIFAZI F; PETRUCCI MT; MILONE G; GUIDI S; GIACCONE L; ROTTA M; FANIN R; BOCCADORO M; CORRADINI P
BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT)VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) INELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE,RANDOMIZED, PHASE III STUDY
2009-01-01 A. Palumbo; S. Bringhen; D. Rossi; R. Ria; S. Berretta; M. Offidani; F. Patriarca; C. Nozzoli; A. Levi; T. Guglielmelli; G. Benevolo; V. Callea; A.M. Liberati; C. Crippa; N. Di Renzo; L. Catalano; G. De Sabbata; R. Rizzi; C. Feo; R. Mazza; G. Farina; A. Spadano; F. Pisani; L. Podda; G. Aitoro; V. Magarotto; M. Astolfi; F. Di Raimondo; G. Gaidano; M. Boccadoro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assortimento per gli aplotipi del sistema HLA come possibile meccanismo di selezione genetica o zigotica | 1969 | A. PIAZZA; MATTIUZ P.L.; CEPPELLINI R. | |
| AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN MULTIPLE MYELOMA: THE GITMO EXPERIENCE | 2003 | Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavaro P; Rotta M; Aitoro G; Corradini P; Todisco E; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Messina M; Palumbo A; Sandmaier B; Storb R; Boccadoro M | |
| Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib | 2016 | Vitale, Candida; Ahn, Inhye E.; Sivina, Mariela; Ferrajoli, Alessandra; Wierda, William G.; Estrov, Zeev; Konoplev, Sergej N.; Jain, Nitin; O’Brien, Susan; Farooqui, Mohammed; Keating, Michael J.; Wiestner, Adrian; Burger, Jan A.* | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS | 2015 | Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS | 2015 | Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Pasquale, R; Sica, S; Laurenti, L | |
| Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin. | 1988 | VISANI G ;RIZZOLI V ;DINOTA A ;AGLIETTA M ;BERNABEI PA ;GERACI L ;LEONI P ;MANGONI L ;MELONI G ;MOTTA MR | |
| Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis | 2002 | Fabris, Fabrizio; Fagioli, Franca; Basso, Giuseppe; Girolami, Antonio | |
| B lymphocytes receptors: a new biological approach for immunofluorescence studies. | 1977 | CONTE PF ;BOCCADORO M ;PILERI A | |
| A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines | 2019 | D'Agaro T.; Zucchetto A.; Vit F.; Bittolo T.; Tissino E.; Rossi F.M.; Degan M.; Zaja F.; Bulian P.; Bo M.D.; Ferrero S.; Ladetto M.; Zamo A.; Gattei V.; Bomben R. | |
| A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial | 2018 | Bomben, Riccardo; Ferrero, Simone; D'Agaro, Tiziana; Dal Bo, Michele; Re, Alessandro; Evangelista, Andrea; Carella, Angelo Michele; Zamò, Alberto; Vitolo, Umberto; Omedè, Paola; Rusconi, Chiara; Arcaini, Luca; Rigacci, Luigi; Luminari, Stefano; Piccin, Andrea; Liu, Delong; Wiestner, Adrien; Gaidano, Gianluca; Cortelazzo, Sergio; Ladetto, Marco; Gattei, Valter | |
| Bases of sensitivity of light chain amyloidosis to proteasome inhibitors: assessing proteostasis and proteasome stress | 2011 | L. Oliva; G. Palladini; F. Cerruti; N. Pengo; P. Cascio; R. Sitia; G. Merlini; S. Cenci | |
| BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. | 2014 | Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
| Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia | 2019 | Diop, Fary; Moia, Riccardo; Favini, Chiara; Spaccarotella, Elisa; De Paoli, Lorenzo; Bruscaggin, Alessio; Spina, Valeria; Terzi-di-Bergamo, Lodovico; Arruga, Francesca; Tarantelli, Chiara; Deambrogi, Clara; Rasi, Silvia; Adhinaveni, Ramesh; Patriarca, Andrea; Favini, Simone; Sagiraju, Sruthi; Jabangwe, Clive; Kodipad, Ahad A; Peroni, Denise; Mauro, Francesca R; Del Giudice, Ilaria; Forconi, Francesco; Cortelezzi, Agostino; Zaja, Francesco; Bomben, Riccardo; Rossi, Francesca Maria; Visco, Carlo; Chiarenza, Annalisa; Rigolin, Gian Matteo; Marasca, Roberto; Coscia, Marta; Perbellini, Omar; Tedeschi, Alessandra; Laurenti, Luca; Motta, Marina; Donaldson, David; Weir, Phil; Mills, Ken; Thornton, Patrick; Lawless, Sarah; Bertoni, Francesco; Del Poeta, Giovanni; Cuneo, Antonio; Follenzi, Antonia; Gattei, Valter; Boldorini, Renzo Luciano; Catherwood, Mark; Deaglio, Silvia; Foá, Robin; Gaidano, Gianluca; Rossi, Davide | |
| Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. | 2006 | Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A | |
| Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy. | 2014 | Mateos MV;Bringhen S;Richardson PG;Lahuerta JJ;Larocca A;Oriol A;Boccadoro M;García-Sanz R;Di Raimondo F;Esseltine DL;van de Velde H;Desai A;Londhe A;San Miguel JF;Palumbo A | |
| Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse | 2005 | MATTEI D; MORDINI N; VIGNA TAGLIANTI R; BRUNO B; RAPEZZI D; GALLAMINI A | |
| Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation | 2006 | BRUNO B; PATRIARCA F; SORASIO R; MATTEI D; MONTEFUSCO V; PECCATORI J; BONIFAZI F; PETRUCCI MT; MILONE G; GUIDI S; GIACCONE L; ROTTA M; FANIN R; BOCCADORO M; CORRADINI P | |
| BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT)VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) INELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE,RANDOMIZED, PHASE III STUDY | 2009 | A. Palumbo; S. Bringhen; D. Rossi; R. Ria; S. Berretta; M. Offidani; F. Patriarca; C. Nozzoli; A. Levi; T. Guglielmelli; G. Benevolo; V. Callea; A.M. Liberati; C. Crippa; N. Di Renzo; L. Catalano; G. De Sabbata; R. Rizzi; C. Feo; R. Mazza; G. Farina; A. Spadano; F. Pisani; L. Podda; G. Aitoro; V. Magarotto; M. Astolfi; F. Di Raimondo; G. Gaidano; M. Boccadoro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile